Similar Papers

Paper Title
Journal
Date
Author
MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.
Xiao-Ping Wang ... Chuan-Bao Chen
Oncotarget | VOL. 8
Xiao-Ping Wang, et. al.Xiao-Ping Wang ... Chuan-Bao Chen
25 Jan 2017
Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model
Yue-Fang Liu ... Bin-Shan Zha
Journal of Experimental & Clinical Cancer Research | VOL. 28
Yue-Fang Liu, et. al.Yue-Fang Liu ... Bin-Shan Zha
29 Jul 2009
Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat.
Philip Carthew ... Elizabeth Martin
Archives of toxicology | VOL. 75
Philip Carthew, et. al.Philip Carthew ... Elizabeth Martin
01 Aug 2001
Changes of serum trace elements, AFP, CEA, SF, T3, T4 and IGF-II in different periods of rat liver cancer
Hong-Xu Zhang ... Peng Zhao
Chinese Journal of Cancer Research | VOL. 23
Hong-Xu Zhang, et. al.Hong-Xu Zhang ... Peng Zhao
01 Dec 2011
View more papers

More From: Oncotarget

Paper Title
Journal
Date
Author
Computed tomography-based radiomics and body composition model for predicting hepatic decompensation.
Yashbir Singh ... Bradley J Erickson
Oncotarget | VOL. 15
Yashbir Singh, et. al.Yashbir Singh ... Bradley J Erickson
22 Nov 2024
Retraction: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.
Xiao-Ping Wang ... Xiao-Peng Yuan
Oncotarget | VOL. 15
Xiao-Ping Wang, et. al.Xiao-Ping Wang ... Xiao-Peng Yuan
22 Nov 2024
Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells.
Zhihong Zhao ... Zhan Liu
Oncotarget | VOL. 15
Zhihong Zhao, et. al.Zhihong Zhao ... Zhan Liu
22 Nov 2024
Advancements in cell-penetrating monoclonal antibody treatment.
Sai Pallavi Pradeep ... Raman Bahal
Oncotarget | VOL. 15
Sai Pallavi Pradeep, et. al.Sai Pallavi Pradeep ... Raman Bahal
22 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.